Synthesis, structure, catalytic transfer hydrogenation and biological activity of cyclometallated ruthenium(III)2-(arylazo)phenolate complexes

A series of mononuclear organoruthenium complexes of the type [RuX(PPh₃)₂(L)] (X = Cl or Br; L = 2-(arylazo)phenolate ligand) have been synthesized from the reaction of five 2-(arylazo)phenol ligands with ruthenium(III) precursors, viz. [RuCl₃(PPh₃)₃] and [RuBr₃(PPh₃)₂(CH₃OH)] in benzene under reflux. In all these reactions, the 2-(arylazo)phenolate ligand replaces one triphenylphosphine molecule, two chlorides or bromides and one methanol from the precursors leading to five-membered cyclometallated species. The 2-(arylazo)phenol ligands behave as dianionic tridentate C, N, O donors and coordinated to ruthenium by dissociation of the phenolic proton and the phenyl proton at the ortho position of the phenyl ring. The compositions of the complexes have been established by elemental analysis, magnetic susceptibility measurement, FT-IR, UV-Vis and EPR spectral data. These complexes are paramagnetic and shows intense d-d and charge transfer transitions in chloroform. The solution EPR spectrum of the complex 7 in dichloromethane at 77 K shows rhombic distortion around the ruthenium ion. The structural conformation of the complex 1 has been carried out by X-ray crystallography. The redox behavior of the complexes has been investigated by cyclic voltammetry and the potentials are observed with respect to the electronic nature of substituents (R) in the 2-(arylazo) phenolate ligands. These complexes catalyze transfer hydrogenation of benzophenone to benzhydrol with up to 99.5% in the presence of i-prOH/KOH. Further, these complexes have shown great promise in inhibiting the growth of both Gram +ve and Gram −ve bacteria, viz. Staphylococcus aureus NCIM 2079 and Escherichia coli NCIM 2065 and fungus Candida albicans NCIM 3102.     

Cyclometallation of phenylhydrazones: Synthesis, reactivity, crystal structure analysis and novel trinuclear palladium(II) cyclometallated compounds with [C, N, N′] terdentate ligands

Reaction of the ligand C₆H₅N(H)NCMe(C₅H₄N) (a) with palladium(II) acetate in toluene gave the mononuclear cyclometallated complex [Pd{C₆H₄N(H)NCMe(C₅H₄N)}(AcO)] (1a). Reaction of 1a with sodium chloride gave the analogous chlorine compound [Pd{C₆H₄N(H)NCMe(C₅H₄N)}(Cl)] (3a) which could also be prepared by reaction of a with lithium tetrachloropalladate and sodium acetate in methanol for 48 h; whereas shorter reaction times afforded the non-cyclometallated complex [Pd{C₆H₅N(H)NCMe(C₅H₄N)}(Cl)₂] (2a). Reaction of the ligand 2-ClC₆H₄N(H)NCMe(C₅H₄N) · HCl (b), with palladium(II) acetate, or with lithium tetrachloropalladate and sodium acetate, yielded the cyclometallated complex [Pd2-ClC₆H₃N(H)NCMe(C₅H₄N)(Cl)] (1b). Treatment of 3a and 1b with silver trifluoromethanesulphonate (triflate) and triphenylphosphine in acetone gave the mononuclear complexes [Pd{2-RC₆H_nN(H)NCMe(C₅H₄N)}(PPh₃)][CF₃SO₃], (R = H, n = 4, 4a; R = Cl, n = 3, 2b) with the ligand as C,N,N′ terdentate and substitution of chlorine by triphenylphosphine. Reaction of 3a and 1b with silver triflate and the tertiary diphosphine Ph₂P(CH₂)₄PPh₂ (dppb) in a 2:1 molar ratio gave the dinuclear cyclometallated complexes [{Pd[2-RC₆H₃N(H)NCMe(C₅H₄N)]}₂(μ-Ph₂P(CH₂)₄PPh₂)][CF₃SO₃]₂ (R = H, 5a; R = Cl, 3b) with a μ₂-diphosphine bridging ligand. Similarly, treatment of 3a and 1b with silver triflate and the tertiary triphosphines MeC(CH₂PPh₂)₃ (tripod) and (Ph₂PCH₂CH₂)₂PPh (triphos), in 3:1 molar ratio, gave the novel trinuclear complexes [{Pd[C₆H₄N(H)NCMe(C₅H₄N)]}₃{μ₃-MeC(CH₂Ph₂)₃}][CF₃SO₃]₃ (6a) and [{Pd[2-ClC₆H₃N(H)NCMe(C₅H₄N)]}₃{μ₃-(PPh₂CH₂CH₂)₂PPh}][CF₃SO₃] ₃ (4b) regioselectively, with the phosphine as a μ₃-bridging ligand. When the reaction between 3a and triphos was carried out in 1:1 molar ratio the mononuclear complex [Pd{C₆H₄N(H)NCMe(C₅H₄N)}{(PPh₂CH₂CH₂)₂PPh-P,P,P}][ClO₄] (7a) was obtained. The crystal structures of 2b, 3a and 4a have been determined by X-ray crystallography.     

Cyclometallated platinum(II) compounds with imine ligands derived from amino acids: Synthesis and oxidative addition reactions

The reactions of [PtMe₂(μ-SMe₂)]₂ with imines 4-ClC₆H₄CHNCHRCO₂Me (R = H (1a), Me (1b), ⁱPr (1c), CH₂C₆H₄(4’-OH) (1d), C₆H₅ (1e), CH₂C₆H₅(1f)) derived from natural amino acids produced under mild conditions cyclometallated platinum(II) compounds [PtMe{κ²-(C,N)-4-ClC₆H₃CHNCHRCO₂Me}(SMe₂)] (2a-2f). These compounds gave the corresponding phosphine derivatives [PtMe{κ²-(C,N)-4-ClC₆H₃CHNCHRCO₂Me}(PPh₃)] (3a-3f). The corresponding cyclometallated platinum(IV) compounds [PtMe₂I{κ²-(C,N)-4-ClC₆H₃CHNCHRCO₂Me}(PPh₃)] (4) arising from intermolecular oxidative addition of methyl iodide were obtained with a high degree of stereo selectivity. Analogous results were obtained for imine 2,6-Cl₂C₆H₃CHNCH(CH₂C₆H₅)CO₂Me (1g) in a process involving intramolecular oxidative addition of a C-Cl bond. The obtained compounds were fully characterized including structure determinations for compounds 3f, 4d and 4f.     

Substituent effects on the cyclo-manganation reaction X-ray crystal structure of Mn{2-(Bu-N=CH) 5-(NO2) C6H3}(CO)4

The cyclometallation reaction between methylmanganese pentacarbonyl and a number of Schiff's bases has been studied. The dependence of the rate of reaction upon ligand substituents has been investigated, demonstrating a rate enhancement with more electron-rich ligands.

The X-ray structure of Mn2-(ⁿBu-N=CH)5-(NO₂)C₆H₃(CO)₄ has been determined.     

Reversible pyranyl complex formation and the mechanism of rearrangement to (η-6-oxocycloheptadienyl)Mn(CO)3 complexes in the reaction of β-cyclomanganated 1,5-diarylpenta-1,4-dien-3-ones and alkynes; the crystal structure of [2,4-diphenyl-6-(2-phenylethenyl)pyranyl-η]tricarbonylmanganese

[1-Phenyl-2-[(E)-3-phenylprop-2-en-1-oyl-κO]ethenyl-κC¹]tetracarbonylmanganese (1a) reacts with PhCCH in CCl₄ at room temperature to form [2,4-diphenyl-6-(2-phenylethenyl)pyranyl-η⁵]tricarbonylmanganese (2a), whose X-ray crystal structure is reported to complement that of its isomer [6-oxo-2,4,7-triphenylcyclohepta-1,4-dienyl-1,2,3,4,5-η]tricarbonylmanganese (3a), previously obtained from the reaction under reflux; but for 1a and PhCCPh the pyranyl complex cannot be isolated before rearrangement to the 3a analogue occurs. More forcing reaction conditions for 1a with Me₃SiCCH and for [1-(2-trifluoromethylphenyl)-2-[(E)-3-(2-trifluoromethylphenyl)prop-2-en-1-oyl-κO]ethenyl-κC¹]tetracarbonylmanganese (1b) with Me₃SiCCH and PhCCH give new analogues of 3a where previously only 2a analogues had been isolated.The reaction in CCl₄ under reflux of PhCCH and the β-deuterio analogue of 1a, [1-phenyl-2-[(E)-3-phenylprop-2-en-1-oyl-3d-κO]ethenyl-κC¹]tetracarbonylmanganese, gave deuteriated 3a with exo-D at the α-carbon, C7. This is inconsistent with the Mn-mediated Ph migration mechanism originally proposed to accommodate the endo position of Ph in 3a, and instead it implicates a cyclopropyl carbonyl-addition intermediate or a cyclopropyl acyl-substitution transition state in the key rearrangement step for 2a → 3a.     

The Influence of Substituents at C2 Carbon Atom of Thiosemicarbazones {R(H)C2=N3‐N2(H)‐C1(=S)‐N1H2} on their Dentacy in PtII/PdII Complexes: Synthesis,Spectroscopy, and Crystal Structures

The coordination chemistry of platinum(II) with a series of thiosemicarbazones {R(H)C²=N³‐N²(H)‐C¹(=S)‐N¹H₂, R = 2‐hydroxyphenyl, H₂stsc; pyrrole, H₂ptsc; phenyl, Hbtsc} is described. Reactions of trans‐PtCl₂(PPh₃)₂ precursor with H₂stsc (or H₂ptsc) in 1 : 1 molar ratio in the presence of Et₃N base yielded complexes, [Pt(η³‐ O, N³, S‐stsc)(PPh₃)] ( 1 ) and [Pt(η³‐ N⁴, N³, S‐ptsc)(PPh₃)] ( 2 ), respectively. Further, trans‐PtCl₂(PPh₃)₂ and Hbtsc in 1 : 2 (M : L) molar ratio yielded a different compound, [Pt(η²‐ N³, S‐btsc)(η¹‐S‐btsc)(PPh₃)] ( 3 ). Complex 1 involved deprotonation of hydrazinic (‐N²H‐) and hydroxyl (‐OH) groups, and stsc^2? is coordinating via O, N³, S donor atoms, while complex 2 involved deprotonation of hydrazinic (‐N²H‐) and ‐N⁴H groups and ptsc^2? is probably coordinating via N⁴, N³, S donor atoms. Reaction of PdCl₂(PPh₃)₂ with Hbtsc‐Me {C₆H₅(CH₃)C²=N³‐N²(H)‐C¹(=S)‐N¹H₂} yielded a cyclometallated complex [Pd(η³‐C, N³, S‐btsc‐Me)(PPh₃)] ( 4 ). These complexes have been characterized with the help of analytical data, spectroscopic techniques {IR, NMR (¹H, ³¹P), U.V} and single crystal X‐ray crystallography ( 1 , 3 and 4 ). The effects of substituents at C² carbon of thiosemicarbazones on their dentacy and cyclometallation are emphasized.     

1-Methyl-4-ferrocenylmethyl-3,5-diphenylpyrazole: A versatile ligand for palladium(II) and platinum(II)

The syntheses and characterization of two novel ferrocene derivatives containing 3,5-diphenylpyrazole units of general formula [1-R-3,5-Ph₂-(C₃N₂)-CH₂-Fc] {Fc = (η⁵-C₅H₅)Fe(η⁵-C₅H₄) and R = H (2) or Me (3)} together with a study of their reactivity with palladium(II) and platinum(II) salts or complexes under different experimental conditions is described. These studies have allowed us to isolate and characterize trans-[Pd{1-Me-3,5-Ph₂-(C₃N₂)-CH₂-Fc]}₂Cl₂] (4a) and three different types of heterodimetallic complexes: cis-[M{1-Me-3,5-Ph₂-(C₃N₂)-CH₂-Fc]}Cl₂(dmso)] {M = Pd (5a) or Pt (5b)}, the cyclometallated products [M{κ²-C,N-[3-(C₆H₄)-1-Me-5-Ph-(C₃N₂)]-CH₂-Fc}Cl(L)] with L = PPh₃ and M = Pd (6a) or Pt (6b) or L = dmso and M = Pt (8b) and the trans-isomer of [Pt{1-Me-3,5-Ph₂-(C₃N₂)-CH₂-Fc]}Cl₂(dmso)] (7b). In compounds 4a, 5a, 5b and 7b, the ligand behaves as a neutral N-donor group; while in 6a, 6b and 8b it acts as a bidentate [C(sp²,phenyl),N(pyrazole)]⁻ group. A comparative study of the spectroscopic properties of the compounds, based on NMR, IR and UV-Visible experiments, is also reported.     

Synthesis and reactivity of new functionalized Pd(II) cyclometallated complexes with boronic esters

Treatment of the functionalized Schiff base ligands with boronic esters 1a, 1b, 1c and 1d with palladium (II) acetate in toluene gave the polynuclear cyclometallated complexes 2a, 2b, 2c and 2d, respectively, as air-stable solids, with the ligand as a terdentate [C,N,O] moiety after deprotonation of the -OH group. Reaction of 1j with palladium (II) acetate in toluene gave the dinuclear cyclometallated complex 5j. Reaction of the cyclometallated complexes with triphenylphosphine gave the mononuclear species 3a, 3b, 3c, 3d and 6j with cleavage of the polynuclear structure. Treatment of 2c with the diphosphine Ph₂PC₅H₄FeC₅H₄PPh₂ (dppf) in 1:2 molar ratio gave the dinuclear cyclometallated complex 4c as an air-stable solid.Deprotection of the boronic ester can be easily achieved; thus, by stirring the cyclometallated complex 3a in a mixture of acetone/water, 3e is obtained in good yield. Reaction of the tetrameric complex 2a with cis-1,2-cyclopentanediol in chloroform gave complex 2c after a transesterification reaction. Under similar conditions complexes 3a and 3d behaved similarly: with cis-1,2-cyclopentanediol, pinacol or diethanolamine complexes 3c, 3b, 3g and 3f, were obtained. The pinacol derivatives 3b and 3g experiment the Petasis reaction with glyoxylic acid and morpholine in dichloromethane to give complexes 3h, and 3i, respectively.     

Intramolecular oxidative addition of C-F and C-H bonds to [Pt(dba)2]. Crystal structure of [PtCl{Me2NCH2CH2NCH(2,4,5-C6HF3)}]

The reactions of compound [Pt(dba)₂] with ligands RCHNCH₂CH₂NMe₂ (1a-1f) in which R is a fluorinated aryl ring produced activation of C-F bonds when two fluorine atoms are present in the ortho positions of the aryl ring or activation of C-H bonds for ligands containing only one fluoro substituent in ortho. Both C-F and C-H bond activation are favoured by an increase of the degree of fluorination of the ring. Further reaction with lithium halides produced cyclometallated platinum (II) compounds [PtX(Me₂NCH₂CH₂NCHR)] (X = Br, Cl) (2) containing a terdentate [C,N,N′] ligand. The obtained compounds were fully characterized including a structure determination for [PtCl{Me₂NCH₂CH₂NCH(2,4,5-C₆HF₃)}] (2d′).